Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-06-27
2008-10-28
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S226500, C514S309000, C514S312000
Reexamination Certificate
active
07442695
ABSTRACT:
The present invention discloses novel depeptidized compounds which have HCV protease inhibitory activity as well as pharmaceutical compositions comprising such compounds and methods of using them to treat disorders associated with the HCV protease.
REFERENCES:
patent: 6608027 (2003-08-01), Tsantrizos et al.
Girijavallabhan Viyyoor M.
Njoroge F. George
Venkatraman Srikanth
Farquharson-Torres Serena
Kalyanaraman Palaiyur S.
Kifle Bruck
Schering Corporation
LandOfFree
Depeptidized inhibitors of hepatitis C virus NS3 protease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Depeptidized inhibitors of hepatitis C virus NS3 protease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Depeptidized inhibitors of hepatitis C virus NS3 protease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4005475